6505-01-304-1014 ( NDC00185-1235-01 , NDC00182-0703-01 , NDC49483-0222-10 , NDC00781-2786-01 , NDC00677-0486-01 , NDC58177-0005-04 , NDC00603-4783-21 , NDC00182-0703-89 , NDC00904-0644-60 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-304-1014 | 6505 | 013041014 | NITROGLYCERIN EXTENDED-RELEASE C | 4260 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AKJF | LONG ACTION METHOD | EXTENDED RELEASE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT |
| CQLS | CAPSULE CONTENT FORM | POWDER |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT |
| CBBL | FEATURES PROVIDED | CHILD RESISTANT CLOSURE |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| AKJC | CAPSULE TYPE | HARD |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00185-1235-01 | 0WTU2 | A | 2 | 5 | 4 | ZZ | |
| NDC00182-0703-01 | 2U436 | A | 2 | 3 | 4 | ZZ | |
| NDC49483-0222-10 | 67225 | A | 2 | 5 | 4 | ZZ | |
| NDC00781-2786-01 | 59043 | F | 9 | 5 | 4 | ZZ | |
| NDC00677-0486-01 | 59225 | A | 2 | 5 | 4 | ZZ | |
| NDC58177-0005-04 | 0TEK5 | A | 2 | 5 | 4 | ZZ | |
| NDC00603-4783-21 | 0ET99 | A | 2 | 5 | 4 | ZZ | |
| NDC00182-0703-89 | 0LXM4 | A | 2 | 5 | 4 | ZZ | |
| NDC00904-0644-60 | 0SYT3 | A | 2 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00185-1235-01 | 0WTU2 | EON LABS INC. | A | A |
| NDC00182-0703-01 | 2U436 | GOLDLINE LABORATORIES | A | A |
| NDC49483-0222-10 | 67225 | TIME-CAP LABS INC | A | A |
| NDC00781-2786-01 | 59043 | GENEVA PHARMACEUTICALS INC | A | F |
| NDC00677-0486-01 | 59225 | BAXTER HEALTHCARE CORP | A | A |
| NDC58177-0005-04 | 0TEK5 | ETHEX CORP | F | A |
| NDC00603-4783-21 | 0ET99 | GENERICS BIDCO I LLC | F | A |
| NDC00182-0703-89 | 0LXM4 | IVAX | F | A |
| NDC00904-0644-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC | F | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 07/12/1 | P | 3004909120 | 4260 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DF | ------- | F | K | U/I CONTAINS 100 EA | |
| DS | N | I | K | U/I CONTAINS 100 EA | |
| DA | C2201X- | A | K | U/I CONTAINS 100 EA | |
| DN | 9B----- | N | K | U/I CONTAINS 100 EA | |
| DM | Z | 1-54--- | M | K | U/I CONTAINS 100 EA |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DA | SMS | L | 1 | BT | M | U | C2201X- | A | |
| DN | SMS | L | 1 | BT | M | U | 9B----- | N | |
| DS | SMS | L | 1 | BT | M | U | D | ||
| DM | SMS | L | 1 | BT | M | U | Z | 1-54--- | M |
| DF | SMS | L | 1 | BT | M | U | ------- | F |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|